Ultragenyx Pharmaceutical Inc.
COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOCHROMATOSIS

Last updated:

Abstract:

This application provides polynucleotides comprising a coding sequence for a functionally active hereditary hemochromatosis protein (HFE) or a functionally active fragment thereof. The invention further provides compositions comprising said polynucleotides and their use in methods of preventing or treating hemochromatosis in a subject.

Status:
Application
Type:

Utility

Filling date:

22 May 2020

Issue date:

14 Jul 2022